Drug Type Therapeutic vaccine |
Synonyms Dendritic cellstimulated vaccine Medinet, Heat shock protein 105 peptidepulsed dendritic cell vaccine Medinet |
Target |
Action inhibitors |
Mechanism HSPH1 inhibitors(Heat shock protein HSP105 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | Japan | 25 Oct 2011 | |
Renal Cell Carcinoma | Clinical | Japan | - |